Cancer clinical trials in the region Pays de la Loire
361 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 3
Head and neck cancer
#NCT05078047
Locally Advanced
Metastatic
Immunotherapy
29 recruiting sites
UNICANCER
Phase 3
Lung cancer
#NCT06119581
#2023-503412-33-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
None
Systemic Treatment-Naive
BRAF
EGFR
HER2
MET
NTRK-1/2/3
RET
ROS-1
Immunotherapy
Chemotherapy
Targeted therapy
18 recruiting sites
Eli Lilly et compagnie
Phase 3
Lung cancer
#NCT06881784
#2024-518154-16-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Other KRAS
HRAS
KRAS G12C
KRAS non G12C
KRAS G12D
NRAS
1
2
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
16 recruiting sites
Revolution Medicines, Inc.
Phase 3
Stomach and esophageal cancer
#NCT06901531
#2024-519773-19-00
Stomach
Oesogastric junction
Adenocarcinoma
Locally Advanced
Metastatic
Claudin 18.2
None
Systemic Treatment-Naive
CPS Positive (1 <= X < 5)
CPS Positive (5 <= X < 10)
CPS Positive (X >= 10)
HER2
Immunotherapy
Chemotherapy
18 recruiting sites
Astellas Pharma Développement mondial, Inc.
Phase 3
Lymphoma
#NCT06091254
B cell lymphoma
Follicular lymphoma
None
Systemic Treatment-Naive
12 recruiting sites
Regeneron Pharmaceuticals
Phase 3
Lung cancer
#NCT06623422
#2023-506327-29-00
NSCLC (Non-Small Cell Lung Cancer)
Localized
Locally Advanced
None
Systemic Treatment-Naive
Systemic Treatment-Naive
ALK
EGFR
Immunotherapy
Immunotherapy
7 recruiting sites
Merck Sharp & Dohme LLC
Phase 3
Colon cancer
Rectal cancer
#NCT06252649
#2022-502352-31-00
Adenocarcinoma
Metastatic
KRAS G12C
None
Systemic Treatment-Naive
Targeted therapy
Targeted therapy
16 recruiting sites
Amgen
Phase 3
Breast cancer
#NCT06790693
#2024-516162-11-00
HER2 Negative
HR Positive
Locally Advanced
Metastatic
PIK3CA
None
Systemic Treatment-Naive
12 recruiting sites
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT06790693
#2024-516162-11-00
HER2 Negative
HR Positive
Locally Advanced
Metastatic
PIK3CA
1
Hormone therapy
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
12 recruiting sites
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT06492616
#2024-515445-42-00
HER2 Negative
HR Positive
Localized
None
Hormone therapy
21 recruiting sites
Stemline Therapeutics, Inc.